Eculizumab Treatment in a Patient with Hematopoietic Stem Cell Transplantation-Associated Thrombotic Microangiopathy and Steroid-Refractory Acute Graft Versus Host Disease.

MLA

Fernández, Cristina, et al. “Eculizumab Treatment in a Patient with Hematopoietic Stem Cell Transplantation-Associated Thrombotic Microangiopathy and Steroid-Refractory Acute Graft Versus Host Disease.” Hematology Reports, vol. 7, no. 4, Dec. 2015, p. 6107. EBSCOhost, https://doi.org/10.4081/hr.2015.6107.

APA

Fernández, C., Lario, A., Forés, R., & Cabrera, R. (2015). Eculizumab Treatment in a Patient with Hematopoietic Stem Cell Transplantation-Associated Thrombotic Microangiopathy and Steroid-Refractory Acute Graft Versus Host Disease. Hematology Reports, 7(4), 6107. https://doi.org/10.4081/hr.2015.6107

Chicago

Fernández, Cristina, Ana Lario, Rafael Forés, and Rafael Cabrera. 2015. “Eculizumab Treatment in a Patient with Hematopoietic Stem Cell Transplantation-Associated Thrombotic Microangiopathy and Steroid-Refractory Acute Graft Versus Host Disease.” Hematology Reports 7 (4): 6107. doi:10.4081/hr.2015.6107.